BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiang J, Shen Y, Zhang Y, Liu X, Zhou Q, Zhou Z, Tang J, Shao S, Shen Y. Multipotent Poly(Tertiary Amine-Oxide) Micelles for Efficient Cancer Drug Delivery. Adv Sci (Weinh) 2022;9:e2200173. [PMID: 35187868 DOI: 10.1002/advs.202200173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen Y, Bae YH. Tumour extravasation of nanomedicine: The EPR and alternative pathways. Adv Drug Deliv Rev 2023;194:114707. [PMID: 36657644 DOI: 10.1016/j.addr.2023.114707] [Reference Citation Analysis]
2 Zhao Z, Feng Y, Xiang J, Liu J, Piao Y, Shao S, Tang J, Zhou Z, Shen Y. Screening of Zwitterionic Liposomes with Red Blood Cell‐Hitchhiking and Tumor Cell‐Active Transporting Capability for Efficient Tumor Entrance. Adv Funct Materials 2023. [DOI: 10.1002/adfm.202214369] [Reference Citation Analysis]
3 Zhang L, Sun J, Huang W, Zhang S, Deng X, Gao W. Hypoxia-Triggered Bioreduction of Poly(N-oxide)-Drug Conjugates Enhances Tumor Penetration and Antitumor Efficacy. J Am Chem Soc 2023;145:1707-13. [PMID: 36601987 DOI: 10.1021/jacs.2c10188] [Reference Citation Analysis]
4 Wu R, Tian M, Shu C, Zhou C, Guan W. Determination of the critical micelle concentration of surfactants using fluorescence strategies. Soft Matter 2022;18:8920-30. [PMID: 36440607 DOI: 10.1039/d2sm01320g] [Reference Citation Analysis]
5 Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y. The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev 2022;191:114614. [PMID: 36347432 DOI: 10.1016/j.addr.2022.114614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fu Z, Du H, Meng S, Yao M, Zhao P, Li X, Zheng X, Yuan Z, Yang H, Cai K, Dai L. Tumor-targeted dual-starvation therapy based on redox-responsive micelle nanosystem with co-loaded LND and BPTES. Mater Today Bio 2022;16:100449. [PMID: 36238964 DOI: 10.1016/j.mtbio.2022.100449] [Reference Citation Analysis]
7 Zhou Q, Li J, Xiang J, Shao S, Zhou Z, Tang J, Shen Y. Transcytosis-enabled active extravasation of tumor nanomedicine. Adv Drug Deliv Rev 2022;189:114480. [PMID: 35952830 DOI: 10.1016/j.addr.2022.114480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu H, Deng Z, Li T, Bu J, Wang D, Wang J, Liu M, Li J, Yang Y, Zhong S. Fabrication, GSH-responsive drug release, and anticancer properties of thioctic acid-based intelligent hydrogels. Colloids Surf B Biointerfaces 2022;217:112703. [PMID: 35853394 DOI: 10.1016/j.colsurfb.2022.112703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ma W, Li S, Ma L, Yu C, Wei H. Multicyclic Topology-Enhanced Micelle Stability and pH-Sensitivity. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111446] [Reference Citation Analysis]
10 Wang Z, Yang L, Li Y, Song S, Qu J, He R, Ren S, Gong P. An activatable, carrier-free, triple-combination nanomedicine for ALK/EGFR-mutant non-small cell lung cancer highly permeable targeted chemotherapy. New J Chem 2022;46:17673-7. [DOI: 10.1039/d2nj03231g] [Reference Citation Analysis]